The USTR has placed India on its "priority watch" list for two years in a row, saying the country's patent laws unfairly favour local drug makers.
Sun Pharma to retain these in most markets; US could be the exception, where the Ranbaxy name has taken a hit.
Broader market outperformed the headline indices with BSE Midcap and Smallcap finishing the day 1.22%, and 1.54% higher, respectively
The Sensex ended at at 27,676, lower by 210 points and the Nifty broke the psychological level of 8,400 to end at 83877 down 70 points.
Based on a writ petition filed by some individual investors, the High Court while ordering the status quo on Friday, issued notices to SEBI, BSE, NSE, Sun Pharma, Ranbaxy, Daichii Sankyo and Silver Street Developers.
A recent report has suggested that future patent expires in the cardiac and anti-diabetes space would form a good opportunity for smaller firms, given their franchise in these segments.
Sebi also ordered freezing the voting rights and corporate benefits of promoters of these companies.
Have conviction in your bets and use stop-loss as a defence mechanism to curtail losses.
Bharti Airtel , RCom and Tata Communications ended down between 0.1-1%.
The broader markets outperformed the benchmark indices- BSE Midcap and Smallcap indices gained 0.4% each
To ensure equal access to health care, the government must consider it in a holistic manner and improve all parameters.
Among these, Hindalco and Vedanta from the metal pack have become multi-baggers, gaining 100 per cent in 2016
Total net debt-equity ratio improves for third consecutive year, while investment in new projects hits a 10-year low, says Krishna Kant.
The Competition Commission of India and the US Federal Trade Commission are yet to give their nod to the biggest pharma merger and acquisition deal this year in the Asia-Pacific region.
Businessman P C Mustafa wants Indian Americans to return home, Cognizant CEO Francisco D'Souza outlines how Indian tech companies could grow, Gaurav Dalmia has some investment recommendations while Subramanian Swamy warns that India is flirting with a debt trap.
The e-commerce sector gave a much higher average hike of 16-20 per cent to its executives.
The S&P BSE Sensex closed 318 points at 24,455 and the Nifty50 shed 99 points to end at 7,438.
'We believe 2017 could see higher flows from foreign institutions as money comes back to growth markets like India.'
Nifty50 surged 145 points to close at 8,468 after hitting an intra-day high of 8,475.
Broader markets outperformed with BSE Midcap and BSE Smallcap adding 0.23% and 0.45%, respectively
Investors will maintain a cautious stance.
Even smaller companies like Torrent Pharma and Alembic file five to 10 ANDAs every year.
Jonathan Garner, chief Asia and emerging markets equity strategist, Morgan Stanley, gives Samie Modak his assessment of the Indian economy after 3 years of Modi Sarkar.
Three IPO documents were recorded after the new govt took charge - Adlabs, Lavasa Corp and Monte Carlo Fashions.
Financials were among the top losers along with Sun Pharma and index heavyweight Reliance Industries
The S&P BSE Sensex ended 80 points up at 23,789 while the Nifty50 closed at 7,235, up 24 points.
The 'Make in India' vision cannot survive in the long-term without concrete measures to build a concurrent 'Create in India' movement.
The failure to reform has meant that there is no buzz about job opportunities, or about urban opportunities enticing young people off the farms. And it is this failure that has contributed to the widespread disappointment that threatens to make the next general elections closer than expected, says Mihir S Sharma.
The top gainers on the Sensex were Cipla, Bharti Airtel, Maruti Suzuki, Hero Moto & Sesa Sterlite.
In a relief to pharma majors, the Delhi high court today held as "illegal and unsustainable" the Centre's decision to put a ceiling on the price of condoms, including the luxury variety.
Though the intent has been hailed as good for the economy, teething problems remain with a five-rate structure for various goods and services
The challenge of merging Ranbaxy into the company has not been factored in.
Expect more volatility in the coming year as the economy and markets price in the demonetisation drive.
Currently, Himalaya sells 250 products across the globe.
Sun Pharma stock has appreciated at 35% a year for 20 years
It could also ease the burden on the 225 million women in developing countries, says Ari Altstedter.
Shares of ING Vysya Bank and Kotak Mahindra Bank rallied by up to 6% on the BSE on reports that Kotak Mahindra Bank in final stages to buy the bank.
Sensex, Nifty put up a good show in closing trade.
While Britain grapples with a hung parliament, EU has warned, 'We don't know when Brexit talks start. We know when they must end.'
'India needs to adopt a more proactive policy of triggering exports to China.'
